Pharmacokinetic Study of Enteric-Coated Sustained-Release Aspirin Tablets in Healthy Chinese Participants

被引:2
|
作者
Cong, Duanduan [1 ]
Qi, Wenyuan [1 ]
Liu, Xiaohui [1 ]
Xu, Xiaoyu [1 ]
Dong, Lingyun [2 ]
Xue, Wei [1 ,3 ]
Li, Kexin [1 ,3 ]
机构
[1] Chinese Acad Med Sci, Beijing Hosp, Inst Geriatr Med, Clin Trial Ctr,Natl Ctr Gerontol,Beijing Key Lab D, Beijing, Peoples R China
[2] Beijing Yeedozencom Healthcare Sci & Technol Co Lt, Beijing, Peoples R China
[3] Beijing Hosp, Clin Trial Ctr, North Bldg B4,1 Dahua Rd, Beijing 100730, Peoples R China
来源
关键词
acetylsalicylic acid; salicylic acid; enteric -coated sustained -release; pharmacokinetics; RESISTANCE;
D O I
10.2147/DDDT.S409524
中图分类号
R914 [药物化学];
学科分类号
100701 ;
摘要
Purpose: To study and compare the pharmacokinetic characteristics of enteric-coated sustained-release (EcSr) aspirin tablets with enteric-coated (Ec) aspirin tablets (Bayer S.p.A) in healthy Chinese participants.Patients and Methods: In this open, randomized, single-dose, three-way, crossover study, 18 healthy participants randomly received 100 mg EcSr tablets pre-prandially (a.c.), EcSr tablets post-prandially (p.c.), or Ec tablets a.c. in each period. The concentrations of acetylsalicylic acid (ASA) and salicylic acid (SA) in plasma were determined by the LC-MS/MS method, and the pharmacokinetic parameters were calculated using WinNonlin (version 8.1).Results: The essential PK parameters under the three treatment conditions (ie Ec a.c., EcSr a.c. and EcSr p.c.) were as follows: Cmax, ASA: 758.38 & PLUSMN;455.34, 222.77 & PLUSMN;98.04 and 194.54 & PLUSMN;61.19 ng, Tmax, ASA: 6.75(2,16), 4.5(2,11) and 8.25(5,11) h, T1/2, ASA: 0.43 & PLUSMN;0.08, 1.44 & PLUSMN;0.59 and 4.32 & PLUSMN;10.04 h, AUC0-t, ASA: 1008.88 & PLUSMN;452.27, 918.04 & PLUSMN;238.40 and 845.55 & PLUSMN;183.25 h & BULL;ng/mL; Cmax, SA: 6409.38 & PLUSMN;2098.52, 2863.53 & PLUSMN;679.73 and 2913.75 & PLUSMN;853.27ng/mL, Tmax, SA: 7.25(2,24), 10(3.5-14) and 10(7,14) h, T1/2, SA: 2.21 & PLUSMN;0.46, 2.69 & PLUSMN;0.72 and 3.51 & PLUSMN;2.06h, AUC0-t, SA: 29,131.41 & PLUSMN;9376.23, 27,243.97 & PLUSMN;7465.16, 27,240.25 & PLUSMN;7444.67 h & BULL;ng/mL. When taking EcSr aspirin tablets, the 90% confidence intervals of the geometric mean ratios (pre-prandial/post-prandial) of AUC0-t, ASA and AUC0-& INFIN;, ASA, Cmax, SA, AUC0-t, SA and AUC0-& INFIN;, SA were within the range of 80.00%-125.00%.Conclusion: EcSr aspirin tablets showed less inter-individual variation in release and absorption than Ec aspirin tablets, which was well reflected by comparing essential PK parameters. Furthermore, meals had no significant effect on the pharmacokinetics of EcSr aspirin tablets.
引用
收藏
页码:2421 / 2429
页数:9
相关论文
共 50 条
  • [1] Pharmacokinetic and pharmacodynamic characteristics of aranidipine sustained-release, enteric-coated tablets in healthy Chinese men: A phase I, randomized, open-label, single- and multiple-dose study
    Jiang, Juanjuan
    Tian, Lei
    Huang, Yiling
    Li, Yishi
    Xu, Li
    CLINICAL THERAPEUTICS, 2008, 30 (07) : 1290 - 1299
  • [2] SUSTAINED ACTION OF ENTERIC-COATED ASPIRIN
    GREEN, DM
    JOURNAL OF NEW DRUGS, 1965, 5 (04): : 256 - &
  • [3] DRUG RELEASE - ENTERIC-COATED TABLETS
    COHEN, JL
    LEESON, LJ
    RHODES, CT
    ROBINSON, JR
    ROSEMAN, TJ
    SHEFTER, E
    HUBERT, BB
    PHARMACOPEIAL FORUM, 1986, 12 (05): : 1810 - 1810
  • [4] Delivery of didanosine from enteric-coated, sustained-release bioadhesive formulation
    Deshmukh, D
    Ravis, WR
    Betageri, GV
    DRUG DELIVERY, 2003, 10 (01) : 47 - 50
  • [5] DISSOLUTION BEHAVIOR OF COMMERCIAL ENTERIC-COATED ASPIRIN TABLETS
    EMBIL, K
    TOROSIAN, G
    JOURNAL OF PHARMACEUTICAL SCIENCES, 1979, 68 (10) : 1290 - 1292
  • [6] ABSORPTION AND METABOLISM OF ASPIRIN ADMINISTERED IN ENTERIC-COATED TABLETS
    LEONARDS, JR
    LEVY, G
    JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1965, 193 (02): : 99 - &
  • [7] EFFECT OF CIMETIDINE ON BIOAVAILABILITY OF ENTERIC-COATED ASPIRIN TABLETS
    PATON, TW
    WALKER, SE
    LEUNG, FYK
    LITTLE, AH
    CLINICAL PHARMACY, 1983, 2 (02): : 165 - 166
  • [8] Pharmacokinetic and bioequivalence evalution of two nimodipine sustained-release tablets in Chinese healthy male volunteers
    Mingyan, Liu
    Huizhe, Wu
    Haijie, Guo
    Minjie, Wei
    JOURNAL OF PHARMACOLOGICAL SCIENCES, 2009, 109 : 210P - 210P
  • [9] KINETICS OF RELEASE FROM ENTERIC-COATED TABLETS
    OZTURK, SS
    PALSSON, BO
    DONOHOE, B
    DRESSMAN, JB
    PHARMACEUTICAL RESEARCH, 1988, 5 (09) : 550 - 565
  • [10] INVITRO AND INVIVO EVALUATION OF SUSTAINED-RELEASE AND ENTERIC-COATED MICROCAPSULES OF DICLOFENAC SODIUM
    HASAN, M
    NAJIB, N
    SULEIMAN, M
    ELSAYED, Y
    ABDELHAMID, M
    DRUG DEVELOPMENT AND INDUSTRIAL PHARMACY, 1992, 18 (18) : 1981 - 1988